Bay Area Biotech on 12/6 →
Professor of Systems Biology, Columbia University
Founder, Gilt Groupe
VP of Research & Policy, Ewing Marion Kauffman Foundation
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Founder, Young Inventors
Managing director, the Foundry Group
Vice President for Research at UT Health Science Center at San Antonio
CEO and Fund Manager, Renaissance Venture Capital Fund
December 5, 2017 ·
December 6, 2017 ·
December 11, 2017 ·
Sponsored · Whitepaper
Reduce turnaround times, cut excessive admin expenses and increas
Moreover, more than half of Fortune 500 pharmaceutical and medica
The pressure has never been greater for life science organizations to shorten the development cycle for new drugs and devices.
The state’s programs for entrepreneurs made a record-setting impact in 2016.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2017, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.